Baltimore, MD, United States of America

Shabazz Novarra

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Becton Dickinson and Company Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shabazz Novarra. Retrieved from https://idiyas.com/inventor/shabazz-novarra-ejzpg090

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shabazz Novarra: Innovator in Coagulation Control

Introduction

Shabazz Novarra is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical devices, particularly in the area of coagulation control. His innovative work has led to the development of a unique patent that addresses critical needs in blood sample analysis.

Latest Patents

Shabazz Novarra holds a patent for "Coagulation controlling agents and devices comprising the same." This invention includes a device, kit, and method for controlling coagulation in a blood sample. The coagulation controlling agent can be one of several substances, including citrate, protamine salt, and their derivatives. The device is designed to stabilize thrombin or enhance its activity in blood samples, which is crucial for accurate medical testing.

Career Highlights

Shabazz Novarra is currently employed at Becton Dickinson and Company Limited, where he continues to work on innovative solutions in the medical device sector. His expertise in coagulation control has positioned him as a valuable asset to his team and the company.

Collaborations

Throughout his career, Shabazz has collaborated with notable colleagues, including Randal A Hoke and Dougald Monroe. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical technologies.

Conclusion

Shabazz Novarra's contributions to coagulation control demonstrate his commitment to improving medical practices through innovation. His patent and ongoing work at Becton Dickinson and Company Limited highlight the importance of advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…